Structure-based de novo design and computational prioritization of candidate allosteric smHDAC8 modulators: a fragment-based strategy against schistosomiasis

Read full text Summarise with VIRAT
Authors: Osvaldo Sánchez López, Ana L. Chávez‐Hernández, Verónica Ramírez-Cid, Marco Antonio Velasco-Velázquez, Luis Córdova-Bahena, Carolina Horta Andrade, Maria Cristina Nonato, Flávio da Silva Emery, José L. Medina‐Franco
Cited by: 0
References: 64

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Schistosomiasis remains a major neglected tropical disease, with praziquantel as the only widely used therapy and limited efficacy against immature parasite stages. Histone deacetylase 8 from Schistosoma mansoni (smHDAC8) is an attractive epigenetic target expressed throughout the parasite life cycle, but achieving isoform selectivity remains challenging due to the high conservation of the catalytic pocket. Targeting allosteric sites offers an alternative strategy to modulate enzyme function while potentially improving selectivity. Here, we disclose nine focused libraries comprising 2,355 unique small molecules generated from synthetic and natural product-derived fragments, including the specialized CRAFT fragment library. The libraries were generated using a fragment-based de novo design strategy targeting an allosteric cavity of smHDAC8 to circumvent selectivity limitations associated with the catalytic site. Consensus virtual screening prioritized 40 candidates, including 20 with high ligand efficiency that outperformed the reference allosteric ligand NF2889. Molecular dynamics simulations further prioritized four compounds that maintained stable interactions within the allosteric pocket and induced changes in long-range residue-correlated motions extending toward the catalytic site. The resulting libraries and prioritized compounds expand the chemical space available for developing non-hydroxamate allosteric smHDAC8 modulators and provide candidates for synthesis, medicinal chemistry optimization, and experimental validation. The main next step is the chemical synthesis and enzymatic evaluation of selected compounds, as well as in vitro/ex vivo studies using relevant parasitic stages. To facilitate their further development by the scientific community, all designed structures, prioritized compounds, associated data, and the computational workflow are made publicly available at https://github.com/DIFACQUIM/De_novo_design_of_focused_smHDAC8_libraries.git .

Fields of Study & Subjects

Computational Drug Discovery Methods Histone Deacetylase Inhibitors Research Cholinesterase and Neurodegenerative Diseases

Publication details

Journal / source
Frontiers in Drug Discovery
Volume
6
Pages
2020639
Publication date
18 November 2026
Language
EN